phillyvoice.com: You've reached your weight loss goal on GLP-1 medications – what now?
GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...
You've reached your weight loss goal on GLP-1 medications – what now?
USA Today: Hers launched a $39 GLP‑1 weight loss membership—here’s what to know
The online health platform Hers has launched a new weight loss membership for GLP-1 treatments. The membership starts at $39 for the first month and then costs $149 per month. Hers offers various ...
The Conversation: You’ve reached your weight loss goal on GLP‑1 medications – what now?
Weight loss on GLP-1 drugs can follow similar patterns as the yo-yo dieting fads of previous decades. RapidEye/iStock via Getty Images GLP-1 drugs have ushered in a new era in weight loss. In just a ...
You’ve reached your weight loss goal on GLP‑1 medications – what now?
The first Instagram, TikTok and Facebook posts by members of the public promoting weight-loss jabs have been banned by the advertising regulator. The posts used discount codes and referral links to ...
Eli Lilly (LLY) shares traded flat on Thursday as J.P. Morgan argued that adverse events overshadowed a potentially best-in-class weight loss profile indicated for its next-gen obesity therapy, ...
Skye Bioscience is rated Buy, driven by nimacimab’s strong safety, durable weight-loss profile, and upcoming Phase 2a results. SKYE’s nimacimab targets the expanding anti-obesity market, showing ...
MSN: Eli Lilly confirms 'superior weight loss' of its next-generation obesity drug